Atlas Trials

Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease

Clinical trial NCT05938140 · UNKNOWN

Trial details

NCT number
NCT05938140
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19Renal Insufficiency, Chronic
Start date
2023-06-22
Primary completion
2025-05-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.